Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Reckitt Benckiser Group PLC Governance Information 2018

Nov 9, 2018

4872_rns_2018-11-09_20a050dc-8863-4ab6-ae67-11d197b06d3e.html

Governance Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9320G

Reckitt Benckiser Group PLC

09 November 2018

9 November 2018

RECKITT BENCKISER GROUP PLC

CHANGE TO REMUNERATION COMMITTEE MEMBERSHIP

Reckitt Benckiser Group plc ("RB") announces that Elane Stock, a Non-Executive Director since 1 September 2018, was appointed as a member of the Board's Remuneration Committee with effect from 8 November 2018.

ABOUT RB

RB is the global leading consumer health, hygiene and home company. Driven by a purpose to build healthier lives and happier homes, RB has operations in over 60 countries. From the foundations of wellness and infant nutrition, to the fundamentals of a hygienic home, our global brands help people live healthier, happier lives.

RB has world leading Powerbrands which include household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. RB's unique culture is at the heart of its success. Its drive to achieve, passion to outperform and commitment to quality and scientific excellence are manifested in the work of over 40,000 RB employees worldwide.

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

For further Information:

Rupert Bondy

Company Secretary

+44 (0) 1753 217 800

Richard Joyce

SVP, Investor Relations

+44 (0)1753 217 800

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOAUGGCAGUPRGGB